Modulation of Protective Immunity, Eosinophilia, and Cytokine Responses by Selective Mutagenesis of a Recombinant G Protein Vaccine against Respiratory Syncytial Virus
Open Access
- 1 April 2005
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 79 (7) , 4527-4532
- https://doi.org/10.1128/jvi.79.7.4527-4532.2005
Abstract
Using anEscherichia coli-grown plasmid vector encoding a fragment of thioredoxin (Trx) fused to a central region (amino acids 128 to 229) of the respiratory syncytial virus (RSV) (Long strain) G protein, we employed site-directed mutagenesis to investigate the importance of selected amino acids to vaccine efficacy. Mice were immunized with a total of 10 wild-type or mutant Trx-G proteins and challenged intranasally with RSV. Striking differences in the induction of RSV G-protein-specific antibodies, protection against RSV challenge, cytokine RNA responses, and induction of RSV-associated eosinophilic inflammation were observed among the mutant proteins examined. Taken together, the results identify a critical role for specific amino acids in the induction of protective immunity and priming for eosinophilia against RSV.Keywords
This publication has 33 references indexed in Scilit:
- Respiratory Syncytial Virus (RSV) G Glycoprotein Is Not Necessary for Vaccine-Enhanced Disease Induced by Immunization with Formalin-Inactivated RSVJournal of Virology, 2004
- Identification of a Common HLA-DP4-Restricted T-Cell Epitope in the Conserved Region of the Respiratory Syncytial Virus G ProteinJournal of Virology, 2004
- Enhanced Disease and Pulmonary Eosinophilia Associated with Formalin-Inactivated Respiratory Syncytial Virus Vaccination Are Linked to G Glycoprotein CX3C-CX3CR1 Interaction and Expression of Substance PJournal of Virology, 2003
- A Role for Immune Complexes in Enhanced Respiratory Syncytial Virus DiseaseThe Journal of Experimental Medicine, 2002
- Differential Histopathology and Chemokine Gene Expression in Lung Tissues following Respiratory Syncytial Virus (RSV) Challenge of Formalin-Inactivated RSV- or BBG2Na-Immunized MiceJournal of Virology, 2001
- Liposome encapsulation of a soluble recombinant fragment of the respiratory syncytial virus (RSV) G protein enhances immune protection and reduces lung eosinophilia associated with virus challengeVaccine, 2000
- Adjuvants influence the quantitative and qualitative immune response in mice immunized with respiratory syncytial virus FG subunit vaccineVaccine, 1997
- The pulmonary immune response of Balb/c mice vaccinated with the fusion protein of respiratory syncytial virusVaccine, 1994
- Vaccines and cytokine-mediated pathology in RSV infectionTrends in Microbiology, 1994
- Viral respiratory tract infection and exacerbations of asthma in adult patients.Thorax, 1988